NCAPD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.303800E-01
Normal-vs-Stage2
9.704600E-01
Normal-vs-Stage3
3.042000E-01
Normal-vs-Stage4
6.367800E-01
Stage1-vs-Stage2
9.217800E-01
Stage1-vs-Stage3
4.065800E-02
Stage1-vs-Stage4
3.503000E-01
Stage2-vs-Stage3
1.864610E-01
Stage2-vs-Stage4
4.618000E-01
Stage3-vs-Stage4
5.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.895400E-01
Normal-vs-AfricanAmerican
9.305200E-01
Normal-vs-Asian
9.964200E-01
Caucasian-vs-AfricanAmerican
8.343000E-01
Caucasian-vs-Asian
9.720800E-01
AfricanAmerican-vs-Asian
9.020800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.579400E-01
Normal-vs-Female
9.027600E-01
Male-vs-Female
2.700600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.971200E-01
Normal-vs-Age(41-60Yrs)
8.514800E-01
Normal-vs-Age(61-80Yrs)
8.905000E-01
Normal-vs-Age(81-100Yrs)
9.354200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.468000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.501200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.780600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.363800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.337200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.648800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.807400E-01
Normal-vs-Daily Drinker
9.473600E-01
Normal-vs-Weekly Drinker
8.123600E-01
Normal-vs-Occasional Drinker
9.863800E-01
Normal-vs-Social Drinker
9.099600E-01
Non Drinker-vs-Daily Drinker
8.154800E-01
Non Drinker-vs-Weekly Drinker
5.295800E-01
Non Drinker-vs-Occasional Drinker
6.746600E-01
Non Drinker-vs-Social Drinker
5.730200E-01
Daily Drinker-vs-Weekly Drinker
6.028600E-01
Daily Drinker-vs-Occasional Drinker
8.846600E-01
Daily Drinker-vs-Social Drinker
7.550200E-01
Weekly Drinker-vs-Occasional Drinker
5.892400E-01
Weekly Drinker-vs-Social Drinker
7.928200E-01
Occasional Drinker-vs-Social Drinker
7.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.461800E-01
Normal-vs-Grade 2
8.968600E-01
Normal-vs-Grade 3
5.475200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.245760E-02
Grade 1-vs-Grade 3
1.541730E-03
Grade 1-vs-Grade 4
9.461800E-01
Grade 2-vs-Grade 3
1.735840E-01
Grade 2-vs-Grade 4
8.968600E-01
Grade 3-vs-Grade 4
5.475200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.408000E-01
Normal-vs-NonDiabetic
9.613600E-01
Diabetic-vs-NonDiabetic
1.499420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.096600E-01
Normal-vs-NoPancreatitis
9.122000E-01
Pancreatitis-vs-NoPancreatitis
1.456370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.168600E-01
Normal-vs-N1
9.817200E-01
N0-vs-N1
6.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.646600E-01
Normal-vs-TP53-NonMutant
9.043800E-01
TP53-Mutant-vs-TP53-NonMutant
2.449500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
